Year All202620252024202320222021202020192018201720162015201420122011 Nov 20, 2024 Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference Nov 8, 2024 Ardelyx Responds to District Court Decision Granting Motion to Dismiss Nov 5, 2024 Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference Oct 31, 2024 Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update Oct 28, 2024 Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting Oct 24, 2024 Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week Oct 22, 2024 Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community Oct 21, 2024 Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community Oct 17, 2024 Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024 Oct 15, 2024 Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week